Search Results - "Palencia, Belen"
-
1
Intratumoral injection of IL-12-encoding mRNA targeted to CSF1R and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
Published in Molecular therapy. Nucleic acids (12-09-2023)“…IL-12 is a potent cytokine for cancer immunotherapy. However, its systemic delivery as a recombinant protein has shown unacceptable toxicity in the clinic…”
Get full text
Journal Article -
2
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models
Published in Oncoimmunology (31-12-2023)“…Previous studies have shown that local delivery of tumor antigen-specific CD8 + T lymphocytes engineered to transiently express single-chain IL-12 mRNA is…”
Get full text
Journal Article -
3
Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8
Published in International journal of cancer (20-08-2005)“…In the course of a clinical trial consisting of intratumoral injections of dendritic cells (DCs) transfected to produce interleukin‐12, the use of…”
Get full text
Journal Article -
4
Potentiation of Therapeutic Immune Responses against Malignancies with Monoclonal Antibodies
Published in Clinical cancer research (15-11-2003)“…Immunotherapeutic monoclonal antibodies (mAbs) can be defined as those that exert their functions by tampering with immune system cell molecules, causing an…”
Get full text
Journal Article -
5
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists
Published in Molecular therapy. Nucleic acids (12-09-2023)“…Intratumoral immunotherapy strategies for cancer based on interleukin-12 (IL-12)-encoding cDNA and mRNA are under clinical development in combination with…”
Get full text
Journal Article -
6
CD137 (4-1BB) and T-Lymphocyte Exhaustion
Published in Clinical cancer research (13-09-2024)“…CD137 (4-1BB) costimulation results in the potent activation of antitumor T lymphocytes and elicits antitumor efficacy that is synergistic with anti-PD(L)1…”
Get full text
Journal Article -
7
Novel strategies exploiting interleukin-12 in cancer immunotherapy
Published in Pharmacology & therapeutics (Oxford) (01-11-2022)“…Interleukin-12 is considered a potent agent to enhance antitumor immune responses. It belongs to a family of heterodimeric cytokines with key roles in the…”
Get full text
Journal Article -
8
Intratumoral injection of IL-12-encoding mRNA targeted to CSFR1 and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
Published in Molecular therapy. Nucleic acids (12-09-2023)“…IL-12 is a potent cytokine for cancer immunotherapy. However, its systemic delivery as a recombinant protein has shown unacceptable toxicity in the clinic…”
Get full text
Journal Article -
9
Facts and Hopes on Neutralization of Protumor Inflammatory Mediators in Cancer Immunotherapy
Published in Clinical cancer research (01-12-2023)“…In cancer pathogenesis, soluble mediators are responsible for a type of inflammation that favors the progression of tumors. The mechanisms chiefly involve…”
Get full text
Journal Article -
10
Intratumoural administration of dendritic cells: hostile environment and help by gene therapy
Published in Expert opinion on biological therapy (01-01-2005)“…Like paratroopers in special operations, dendritic cells (DCs) can be deployed behind the enemy borders of malignant tissue to ignite an antitumour immune…”
Get more information
Journal Article -
11
Low-dose ionizing γ-radiation elicits the extrusion of neutrophil extracellular traps
Published in Clinical cancer research (13-09-2024)“…Cancer patients frequently undergo radiotherapy in their clinical management with unintended irradiation of blood vessels and copiously irrigated organs in…”
Get full text
Journal Article -
12
Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity
Published in Cancer immunology research (03-02-2023)“…IL12-based local gene therapy of cancer constitutes an active area of clinical research using plasmids, mRNAs, and viral vectors. To improve antitumor effects,…”
Get more information
Journal Article -
13
Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer
Published in Expert opinion on biological therapy (01-05-2007)“…There is compelling evidence for the role of natural killer (NK) cells in tumor immunosurveillance and their beneficial effects on many experimentally…”
Get more information
Journal Article -
14
Effective tumor immunotherapy: start the engine, release the brakes, step on the gas pedal,...and get ready to face autoimmunity
Published in Archivum Immunologiae et Therapiae Experimentalis (2002)“…Cellular immune responses can destroy cancer cells, achieving the cure of experimental malignancies. An expanding wealth of knowledge on the molecular basis of…”
Get more information
Journal Article -
15
Interferon producing killer dendritic cells (IKDC): A matter of controversy
Published in Inmunología (1987) (2010)“…Abstract Division of labour among cells of the immune system is a prevailing theme in the orchestration of immune responses. Contrary to this paradigm, a…”
Get full text
Journal Article -
16
Potenciales evocados cognitivos en el trastorno por déficit de atención con hiperactividad
Published in Revista de neurologiá (16-02-2002)Get full text
Journal Article